Tomas J. Kiselak
Angel · Massachusetts
Board director at 3 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- May 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Spyre TherapeuticsJul 6, 2023
- SEC Form D: Interius BioTherapeuticsOct 20, 2023
- SEC Form D: Zenas BioPharmaMay 14, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.